Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that St.Vincent Indianapolis Hospital has renewed its campus-wide contract for Masimo SET pulse oximetry technology.
A Masimo customer since 2000, St.Vincent cites advanced monitoring technology, an upgradeable platform, and innovative new capabilities as key reasons for the six-year system-wide renewal of their technology standardization contract, which will continue to support the oximetry needs of the quaternary facility.
"All pulse oximetry technologies are not created equal," stated Kathy Gatons, BA, RRT, Director of Clinical Support at St.Vincent Hospital. "Masimo offers the best, most advanced oximetry technologies available. We know the measurements can be trusted and the alarms are valid when a Masimo pulse oximeter is on the patient. That's why we chose to standardize on Masimo SET 10 years ago and why we continue to leverage Masimo as our pulse oximetry platform for the future. Patient safety is a huge initiative that we support by placing Masimo technology at every patient bedside."
Continuing their standardization on Masimo SET pulse oximetry technology allows St.Vincent Hospital to leverage the unique breakthrough noninvasive blood constituent monitoring capabilities of Masimo Rainbow SET Pulse CO-Oximetry. Masimo Rainbow SET is the first-and-only technology platform capable of continuously and noninvasively measuring multiple blood constituents and parameters that previously required invasive procedures, including: total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), PVI® for fluid responsiveness, and acoustic respiration rate (RRa(TM)), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI). The ability to immediately detect and treat potentially life-threatening conditions without having to draw blood and wait for the results facilitates earlier and better clinical decisions that may help St.Vincent clinicians to save lives and improve patient outcomes.
According to Rex McKinney, MBA, RRT, CHP, FACHE, Executive Director, Clinical Support Services at St.Vincent Hospital, "Masimo has excelled at providing leading technology that we need to support our patient safety initiatives. St.Vincent places the highest priority on providing healthcare that is safe. The Masimo technology platform provides our clinicians with the tools to monitor patients effectively and provide the safest clinical setting possible."
Masimo Founder and CEO, Joe E. Kiani, stated, "As an early adopter of Masimo SET technology, St.Vincent was one of the first hospitals to see the clinical value and patient impact of Masimo technology. Today, their unwavering commitment to delivering the best possible patient outcomes and remaining on the front line of medical advances is as strong as ever. And, we are happy that they have chosen to bring the latest noninvasive technologies to the patients they serve with Masimo Rainbow SET - helping provide faster, more accurate diagnosis, treatment, and recovery to those in need."
Breaking through new research barriers with iPSC technology